XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenue, net
Operating expenses:        
Research and development 457,627 355,891 1,520,870 1,198,966
General and administrative 1,339,448 985,390 4,401,158 1,868,342
Total operating expenses 1,797,075 1,341,281 5,922,028 3,067,308
Loss from operations (1,797,075) (1,341,281) (5,922,028) (3,067,308)
Other income (expense)        
Interest income (expense) 11,332 33 (1,334,612) 724
FMV gain (loss) adjustment for derivatives (635,283) 3,443,647
Other 14,896 14,896
Foreign exchange gain 8,007 8,007
Total Other Income (Expense) (601,048) 33 2,131,938 724
Net loss $ (2,398,123) $ (1,341,248) $ (3,790,090) $ (3,066,584)
Net loss per share, basic and diluted $ (0.26) $ (0.27) $ (0.49) $ (0.62)
Weighted average shares used to compute net loss per share, basic and diluted 9,207,386 4,945,010 5,959,577 4,789,670
Other comprehensive loss        
Foreign currency translation $ (190,863) $ (190,863)
Total Comprehensive Loss $ (2,588,986) $ (1,341,248) $ (3,980,953) $ (3,066,584)